Biotechnology News

June 30, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck Announces Data from Investigational Phase 3 Study on EMEND® (aprepitant) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children Undergoing Emetogenic Chemotherapy.

June 30, 2014

SAN DIEGO, Calif.--(BUSINESS WIRE)--Cidara Therapeutics Completes $32 Million Series A Financing

June 30, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles Transnational Holdings Inc. (NYSE: Q) will release its financial results for the second quarter of 2014 prior to its quarterly earnings call on Thursday, July 31, 2014, at 8:00 a.m. EDT.

June 30, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ: OPXA), today announced its addition to the Russell Microcap® Index.

June 30, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals announced preclinical data demonstrating the promise of DCR-PH1, the Company’s therapeutic candidate for the treatment of primary hyperoxaluria type 1 (PH1).

June 30, 2014

MALVERN,Pa.--(BUSINESS WIRE)--Aclaris Therapeutics Announces Positive Results from Phase 2 Clinical Trial of A-101 for the Removal of Seborrheic Keratosis, a Common Type of Skin Tumor

June 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT:SAN and NYSE:SNY), announced today that Argentina’s National Administration of Drugs, Food and Medical Technology (ANMAT) has approved LemtradaTM (alemtuzumab) for adult...

June 30, 2014

JUPITER, Fla.--(BUSINESS WIRE)--BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCBB:BRTX), a life sciences company focused on adult stem cell-based cellular therapies for various personal medical applications, today announced the...

June 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, announced today that it has been added to the Russell 1000 Index, effective June 27, 2014. The Russell 1000 Index measures the...

June 30, 2014

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company Added to the Russell Microcap Index

June 30, 2014

PORTLAND, Ore.--(BUSINESS WIRE)--Sedia Biosciences will give a scientific presentation on a new rapid HIV incidence assay at the July 2014 International AIDS Conference in Melbourne, Australia. We will also have a commercial exhibit.

June 30, 2014

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) announced today the company was added to the Russell 2000® and Russell 3000® Indexes following the reconstitution of Russell Investment Group's family of US indexes after the market closed...

June 30, 2014

HOLLISTON, Mass.--(BUSINESS WIRE)--Harvard Apparatus Regenerative Technology, Inc.(NASDAQ:HART), announces its HART-Trachea was spotlighted in a two-hour-long NBC-TV News Special on Friday, June 27.

June 30, 2014

LAS VEGAS--(BUSINESS WIRE)--Medican Enterprises, Inc. (OTCBB:MDCN) a bio-pharmaceutical company in the emerging global medical marijuana industry is pleased to announce it is currently negotiating the purchase of 51% of International Herbs...

June 30, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on harnessing the potential of hypoxia-inducible factor (HIF) biology to develop and commercialize novel therapeutics to treat kidney...

June 30, 2014

INGELHEIM, Germany--(BUSINESS WIRE)--For media outside of the U.S., the UK & Canada only The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to the investigational antidote idarucizumab* (a humanized...

June 30, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--MSD’s Investigational Anti-PD-1 Antibody, Pembrolizumab, Under Regulatory Review in Europe for the Treatment of Advanced Melanoma.

June 30, 2014

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that it was added to the Russell 3000® and Russell 2000® Indexes when the Russell...

June 30, 2014

PASADENA, Calif.--(BUSINESS WIRE)--ALS biomarker report for Genervon’s Clinical Trial: 6 biomarkers were modulated by GM604 significantly - two of the biomarkers achieved statistical significance between the treated and placebo groups.

June 30, 2014

CAMBRIDGE, England--(BUSINESS WIRE)--Isogenica, Cambridge UK and Imperial College London secure funding from UK's Technology Strategy Board to develop gene library synthesis for synthetic biology.

June 30, 2014

CHALFONT ST. GILES, England--(BUSINESS WIRE)--GE Healthcare today announced the receipt of a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP). This opinion recommends the granting of a...

June 30, 2014

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it has entered into separate agreements with Biomnis, Genoma, and the Center for Human Genetics and Laboratory Diagnostics Martinsried, under which they will use the...

June 27, 2014

WASHINGTON--(BUSINESS WIRE)--Xenex Disinfection Services, the world leader in UV room disinfection systems, testified yesterday before the U.S. House of Representatives Committee on Science, Space, and Technology; Subcommittee on Research and...

June 27, 2014

OSAGE, Iowa--(BUSINESS WIRE)--Valent BioSciences Corporation (VBC) today marked the official opening of its new $146 million biorational manufacturing facility in Osage, IA in a ceremony that included more than 130 international dignitaries,...

June 27, 2014

WILLOW GROVE, Pa.--(BUSINESS WIRE)--This week, the National Institute for Standards and Technology (NIST) announced that Dr. Barry Logan, Vice President of Forensic Science Initiatives at NMS Labs and Executive Director of the Center for Forensic...

June 27, 2014

NEW HAVEN, Conn.--(BUSINESS WIRE)--Kolltan Pharmaceuticals, a privately held biopharmaceutical company focused on the development of novel biologics targeting receptor tyrosine kinases, today announced key developments within its leadership team...

June 27, 2014

LOS ANGELES--(BUSINESS WIRE)--Federico Pignatelli, former CEO and current director and stockholder of Biolase, Inc. (Nasdaq:BIOL), has initiated a process pursuant to Section 220(b) and (d) of the Delaware General Corporation Law to obtain...

June 27, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical-stage biopharmaceutical company developing nucleotide therapeutics for patients with cancer and orphan diseases, today announced that it will be added to...

June 27, 2014

OTTAWA, Ontario--(BUSINESS WIRE)--Nordion Inc. (TSX:NDN) (NYSE:NDZ) announced today that it and Sterigenics International LLC (“Sterigenics”) have each received a request for additional information (a “Second Request”) from the Federal Trade...

June 27, 2014

EYSINS, Switzerland--(BUSINESS WIRE)--Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor) in Eight Non-G551D Gating Mutations

June 27, 2014

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that...

June 27, 2014

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted...

June 27, 2014

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Limited (NYSE: RDY) today announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements for the fiscal year ended 31 March, 2014 was filed with...

June 27, 2014

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Duloxetine Delayed-Release Capsules USP 20 mg, 30 mg and 60 mg, a therapeutic equivalent generic version of CYMBALTA® (Duloxetine Delayed...

June 27, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company has submitted a New Drug Application (NDA) to Japan’s Pharmaceutical and Medical Devices Agency (PMDA) for approval of sofosbuvir, a once-...

June 27, 2014

IRVINE, Calif.--(BUSINESS WIRE)--BIOLASE announces 2014 Annual Meeting of Shareholders will be held on August 27, 2014 and has established July 22, 2014 as the record date.

June 27, 2014

SAN DIEGO--(BUSINESS WIRE)--The 2014 BIO International Convention, where the global biotech community meets, connecting the people, companies and innovations that help to fulfill the promise of biotechnology through healing, fueling, and feeding...

June 26, 2014

ST. LOUIS--(BUSINESS WIRE)--Monsanto Company (NYSE: MON) today announced the pricing of $4.5 billion aggregate principal amount of fixed rate senior notes consisting of the following: $500 million in senior notes that mature in 2017 and bear...

June 26, 2014

TORONTO--(BUSINESS WIRE)--ANTIBE THERAPEUTICS ANNOUNCES FIRST HUMAN DOSE OF ATB-346 IN PHASE I CLINICAL TRIAL

June 26, 2014

VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it has completed the acquisition of a minority stake in Profarma Distribuidora de Produtos Farmacêuticos S.A. (Profarma), a leading pharmaceutical...

June 26, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) will host a quarterly conference call to discuss its second quarter 2014 financial results on Thursday, July 17, 2014, at 7:30 a.m. central time. To access the call, please...

June 26, 2014

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Today, Ambry Genetics and the Mauli Ola Foundation (MOF) announced the Battle for the Breasts, an online surf video contest, powered by Surfline. The goal of this three-month event is to increase public...

June 26, 2014

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Netsmart named for eighth time to HCI 100 list of top 100 healthcare IT vendors by revenue, and the list's only health and human services-focused technology provider.

June 26, 2014

MALVERN, Pa.--(BUSINESS WIRE)--Siemens Healthcare has announced that it recently submitted to the U.S. Food and Drug Administration (FDA) its premarket approval application (PMA) for the MAMMOMAT Inspiration® with Breast Tomosynthesis option. In...

June 26, 2014

COLUMBUS, Ohio--(BUSINESS WIRE)--Citing their personal health problems and costs incurred, Ohio women who have been seriously injured by pelvic mesh implants requested that Ohio Attorney General Mike DeWine investigate the pelvic mesh industry...

June 26, 2014

SAN DIEGO--(BUSINESS WIRE)--BIO 2014 enters its fourth and final day today at the San Diego Convention Center and will feature the Annual Scientific American WorldView Scorecard and BIO Idea Hackathon.